Thu. Apr 25th, 2024

Uncategorized

National Rapid Assessment Report on Institutional impact of COVID-19 among People of Color Community-Based Providers

For Immediate Release (ver versión en español abajo) Contact: Luis Scaccabarrozzi Lscaccabarozzi@latinoaids.org; Aaron Chandler AaronC@blackaids.org; Lance Toma lance@sfcommunityhealth.org National Rapid Assessment Report on Institutional impact of COVID-19 among People of Color Community-Based Providers New York, NY, February 22, 2020 - We are proud to release the Final Report of the National Rapid Assessment on the Institutional Impact of COVID-19 on Organizations Providing

National Hispanic/Latinx Health Leadership Network Releases Federal Health Policy Agenda “Our Health, Our Future”

New York, NY September 9, 2020—The National Hispanic/Latinx Health Leadership Network is proud to share the first ever community driven federal health policy agenda. The health policy agenda was finalized through a community participatory process in 2020, after close to two years of arduous work from over 200 organizations and

European Commission Grants Authorization for Gilead’s Veklury® (remdesivir) for Treatment of COVID-19

- Veklury is the First Approved Treatment Option for COVID-19 in the European Union -- FOSTER CITY, Calif.--(BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the European Commission has granted conditional marketing authorization for Veklury®(remdesivir) as a treatment for SARS-CoV-2 infection, the virus that causes COVID-19. The conditional marketing

Protecting COVID 19 Contact Tracing Data

AS CONTACT TRACING IS ROLLED OUT ACROSS THE STATE, ADVOCATES RAISE THE ALARM ABOUT THE WEAPONIZATION OF  INTIMATE HEALTH INFORMATION BY POLICE AND ICE AT PRESS CONFERENCE, CIVIL RIGHTS GROUPS, HEALTH ADVOCATES & PUBLIC DEFENDERS URGE PASSAGE OF BILL PROTECTING CONFIDENTIALITY OF CONTACT TRACING DATA NEW YORK—Today, local and national civil rights